Aerovate Therapeutics Presents Baseline Data From The Phase 2B Portion Of The IMPAHCT Trial At The American Thoracic Society 2024 International Confer...
Baseline characteristics reflect a PAH population with significant disease Topline data from Phase 2b portion of IMPAHCT study to be